Abstract Body

Beside hemostasis, human platelets exert several immune functions and interact with infectious pathogens including HIV that platelet internalize in vitro. Yet, in vivo evidence for HIV-containing platelets and their role in AIDS remain elusive. Immunological non-responder patient (InR) represents 20% of overall cART treated patients for which no clear treatment is available so far. In InR, serum concentration is inversely associated with low CD4+T-cell counts.

Infectious HIV content in platelets was quantified by qPCR, FISH-Flow, microscopy, and reporter cell assays using platelet-rich-plasma (PRP) from 78 HIV-infected cART-treated adult patients. The capacity of platelet-containing HIV to propagate infection was evaluated by culturing human primary macrophages with PRP without or with the platelet activation-blocker Abciximab. The presence of HIV in platelets was correlated with patient clinical status over 3 years.

We found that in cART-treated patients, with detectable but also undetectable viral loads, platelets enclose infectious HIV, as shown by the presence of viral RNA, p24-Gag, intact virus localization within platelet internal compartments and infection of reporter cells. Macrophage internalize platelets sheltering HIV in vitro, resulting in turn in productive macrophage infection together with an increase in IL-7 secretion. Both macrophage infection and IL-7 secretion are blocked by the therapeutical agent Abciximab, a platelet activation/aggregation inhibitor. Analysis of patient clinical data revealed that the detection of HIV-carrying platelets is independent of platelet counts, viremia and time since infection, but strongly correlates with sustained low blood CD4+T-cell counts (<350cells/microL in a 3 years survey) and nadir (<200cells/ml). Thus, 65.2% of patients sheltering HIV in platelets do not respond immunologically to cART and fail to restore a proper CD4+T cell counts over 18 months with a >20-fold higher likelihood than patients without HIV in platelets (OR:21.3, 95%CI:4.4-103.1, p<0.001).

HIV shelter in patient platelets represent alternative, but transient and numerically important carriers of infectious viruses that can fuel tissue HIV reservoirs. Detection of HIV within platelets in correlation with failure of immunological recovery together with the capacity of Abciximab to block HIV transfer from platelets to target cells suggest new diagnostic and therapeutic perspectives to improve prediction and immunological recovery in InR